T&I AsiaWatch for April 25th, 2022
We're waiting for a shoe to drop in Asia, but instead, creeping inflation, investment valuation loss and volatility will be the order of our spring.
Editor’s Note: It was one of 2022’s most active M&A weeks with alternatives deals by AMP, Cerberus, Hines, KKR, Macquarie, OTPP, and others. Listed GPs? They’re not in hell, but the view of that destination from here (30% to 50% down) is scary. Multiple China IPOs were withdrawn or found trouble on the way to re-list on HKEX. India? Two PE IPOs filed, s…